Breaking news

Cyprus’ Pharmaceutical Dependence: Analyzing The EU’s Trade Dominance

Cyprus heavily depends on imported medicine, with only 40% of authorized pharmaceutical products available locally, as outlined in a European Commission report. Notably, around 20% of these medicines come through Article 5 of Directive 2001/83/EC, addressing unique medical needs without standard marketing approvals.

Moves Toward Better Access

Efforts are underway to improve the situation in Cyprus, as well as in Malta and Ireland. Suggested strategies include simplifying drug authorization, encouraging multi-country packaging solutions, and utilizing digital platforms to overcome language barriers.

EU’s Pharma Trade Boom

Despite these challenges in smaller member states, the European Union recorded a remarkable pharmaceutical trade surplus last year—analyzing the trends shows a 13.5% increase in exports, reaching €313.4 billion while maintaining a €193.6 billion trade surplus.

Leading the export charge, Germany achieved €67.9 billion, with Ireland and Belgium following closely. Meanwhile, Germany also led imports, indicating dynamic intra-EU trade flows.

Global Trade Dynamics

The United States dominates as the EU’s top pharmaceutical trading partner, followed by Switzerland and the United Kingdom. These relationships underscore the EU’s strong global position in the pharmaceutical sector.

Copyright Law Struggles To Keep Up With AI Training

Courts Are Still Applying Old Copyright Rules To AI

AI companies train models on enormous amounts of published material, including books, articles and academic research. Whether using that content without authors’ permission violates copyright law remains unresolved.

Much of the debate centres on fair use, which allows copyrighted material to be used without permission in certain circumstances. Courts consider factors such as the purpose of the use, how much material was involved and its impact on the original market.

Anthropic Case Sets An Important Precedent

A major case involving Anthropic and a group of authors provided one of the clearest rulings so far. Judge William Alsup found that using copyrighted books to train AI models was lawful, comparing the process to people reading and studying literature before creating something new.

Anthropic was nevertheless ordered to pay $1.5 billion in a settlement. The penalty concerned books the company had obtained from illegal online libraries rather than the AI training itself.

For AI companies, that distinction could prove significant because it separates studying copyrighted material from directly copying it.

Competition Could Be The Key Issue

A case involving Thomson Reuters and Ross Intelligence offers a different perspective. A court ruled that Ross could not claim fair use after using Reuters’ copyrighted material to develop a competing AI-powered legal research platform.

The decision suggests courts may be less willing to consider AI training fair use when copyrighted content is used to build a product that directly competes with the original.

For authors, an unresolved question is whether AI-generated content should be considered competition for the works used to train these models.

The Law Has Yet To Catch Up

US copyright law predates generative AI by decades, leaving courts to apply old principles to new technology. Questions also remain over copyright protection for AI-generated works. In Thaler v. Perlmutter, a court ruled that material created entirely by AI cannot receive copyright protection.

Major AI companies remain involved in copyright litigation, and different courts could reach different conclusions. For now, there is no universal rule: the legality of AI training will depend on the circumstances of each case and how courts ultimately interpret copyright and fair use.

Uol
The Future Forbes Realty Global Properties
Aretilaw firm
eCredo

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter